No Data
No Data
SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS To Go Ex-Dividend On April 19th, 2024 With 0.51638 USD Dividend Per Share
March 27th - $SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US)$ is trading ex-dividend on April 19th, 2024. Shareholders of record on April 22nd, 2024 will receive 0.51638 USD di
Siemens Healthcare grew strongly in the first quarter, laying a solid foundation for the 2024 fiscal year
ERLANGEN, Germany, Feb. 1, 2024/PRNewswire/ -- Siemens Healthcare today released its results report for the first quarter of the 2024 fiscal year ending December 31, 2023. The equipment order shipment ratio in the first quarter of FY2024 was as high as 1.14, excluding the rapid COVID-19 antigen testing business, which was a strong increase of 7.0%; taking into account the rapid COVID-19 antigen testing business that had been terminated in the fourth quarter of FY2023, comparable revenue increased 5.7%, and the imaging business increased 5.3% compared to revenue; due to the adverse effects of the short-term business portfolio, adjusted profit before interest and tax
Siemens Healthineers Profit Rises on Revenue Growth
By Adria Calatayud Siemens Healthineers reported a rise in net profit for the first quarter of fiscal 2024, helped by higher sales driven by growth in its Varian radiation-oncology business. Net pro
GE HealthCare Falls as UBS Cut to Sell on Valuation
Siemens Healthcare confirms participation in the 7th China International Import Expo
SHANGHAI, November 8, 2023/PRNewswire/ -- On November 8, Siemens Healthcare signed a formal contract with the China International Import Expo Bureau to confirm participation in the 7th China International Import Expo. Liu Fuxue, Deputy Director of the China International Import Expo Bureau (second from left) and Siemens Healthcare Greater China President Wang Hao (second from right) attended and witnessed the signing ceremony
Siemens Healthcare performed strongly in the fourth quarter and ended fiscal year 2023 successfully
ERLANGEN, GERMANY, November 8, 2023/PRNewswire/ -- Siemens Healthcare recently released results reports for the fourth quarter of fiscal year 2023 and the full year of fiscal year 2023 and the full year of fiscal year 2023 ending September 30, 2023. FY2023: Revenue growth and earnings per share targets both reached equipment order delivery ratio of 1.15 Excluding the rapid COVID-19 antigen testing business, comparable revenue increased significantly by 8.3%; the rapid COVID-19 antigen testing business was terminated in the fourth quarter. Including this business, comparable revenue increased by 1.2%, and Varian Healthcare's comparable revenue grew strongly by 14.8 percent
No Data